SSA
AGIO icon

Schonfeld Strategic Advisors’s Agios Pharmaceuticals AGIO Stock Holding History

Schonfeld Strategic Advisors’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19.3M Buy
520,083
+320,022
+160% +$9.71M 0.07% 256
2026
Q1 		$6.77M Buy
+200,061
New +$5.67M 0.05% 404
2025
Q3 		– Sell
-46,346
Closed -$1.54M – 2165
2025
Q2 		$1.54M Buy
46,346
+22,746
+96% +$689K 0.01% 1113
2025
Q1 		$691K Sell
23,600
-7,552
-24% -$251K ﹤0.01% 1444
2024
Q4 		$1.02M Buy
31,152
+130
+0.4% +$6.11K 0.01% 1101
2024
Q3 		$1.38M Sell
31,022
-433,099
-93% -$19.7M 0.01% 1038
2024
Q2 		$20M Buy
+464,121
New +$16.8M 0.13% 166
2023
Q1 		– Sell
-23,700
Closed -$665K – 2057
2022
Q4 		$665K Buy
+23,700
New +$668K 0.01% 1363
2022
Q1 		– Sell
-11,300
Closed -$371K – 2558
2021
Q4 		$371K Buy
+11,300
New +$455K ﹤0.01% 1420
2021
Q3 		– Sell
-22,035
Closed -$1.21M – 2122
2021
Q2 		$1.21M Sell
22,035
-5,701
-21% -$319K 0.01% 866
2021
Q1 		$1.43M Buy
+27,736
New +$1.37M 0.02% 768
2020
Q4 		– Sell
-22,428
Closed -$785K – 1536
2020
Q3 		$785K Buy
22,428
+16,094
+254% +$705K 0.01% 774
2020
Q2 		$339K Sell
6,334
-134
-2% -$6.21K 0.01% 953
2020
Q1 		$229K Buy
+6,468
New +$299K 0.01% 860
2016
Q4 		– Sell
-11,000
Closed -$581K – 532
2016
Q3 		$581K Buy
+11,000
New +$479K 0.1% 254
2016
Q2 		– Sell
-7,841
Closed -$318K – 420
2016
Q1 		$318K Buy
+7,841
New +$335K 0.13% 210

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Schonfeld Strategic Advisors's AGIO Position: Q2 2026 in Review

Schonfeld Strategic Advisors increased its Agios Pharmaceuticals (AGIO) stake by 160% in Q2 2026, buying an estimated $9.71M and bringing the position to 520,083 shares worth $19.3M. The position accounts for 0.07% of the portfolio, ranked #256.

Schonfeld Strategic Advisors first reported a position in AGIO in Q1 2016 and has held it in 16 quarters since. The position peaked at $20M in Q2 2024. 239 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • Schonfeld Strategic Advisors held 520,083 shares of Agios Pharmaceuticals worth $19.3M as of Q2 2026.
  • Schonfeld Strategic Advisors bought 320,022 Agios Pharmaceuticals shares in Q2 2026, an estimated $9.71M.
  • Agios Pharmaceuticals made up 0.07% of Schonfeld Strategic Advisors's portfolio in Q2 2026, its #256 holding.
  • Schonfeld Strategic Advisors first reported a position in Agios Pharmaceuticals in Q1 2016 and has held it in 16 quarters since.
  • Schonfeld Strategic Advisors's Agios Pharmaceuticals position peaked at $20M in Q2 2024.
  • 239 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.